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KEY FINDINGS– 2014 HIV DATA  
In 2014, 377 new HIV diagnoses were notified in Ireland, giving a crude notification rate of 8.2 
per 100,000 population. This is an increase of 11% compared to 2013 and can be accounted 
for by an increasing number of HIV notifications among men who have sex with men (MSM) 
and people who inject drugs (PWID). Between 2010 and 2013, the annual rate of new HIV 
diagnoses had been relatively stable in Ireland, ranging from 7.0 to 7.5 per 100,000 
population.   
 
Probable route of transmission was known for 89% of new diagnoses in 2014. As in recent 
years, the highest number of new diagnoses was among MSM (183; 49%); and this is the 
highest number ever reported in MSM in Ireland. In the 10 years since 2005, the number of 
new diagnoses among MSM has increased threefold (from 60 to 183) and the median age at 
diagnosis has dropped from 37 to 31 years.  
 
Heterosexual contact was the second most commonly reported mode of transmission in 2014, 
(125; 33%). Since 2010, the number of diagnoses among heterosexuals has remained stable, 
ranging from 125 to 133 diagnoses per year. The majority of heterosexuals (62%) diagnosed in 
2014 were born in countries with generalised HIV epidemics[1]. The proportion diagnosed late 
in male heterosexuals (71%) was higher than in previous years (60% in 2013 and 68% in 2012) 
while in female heterosexual cases, the proportion diagnosed late (56%) was less than 
previous years (59% in 2013 and 58% in 2012).  
 
There were 27 (7%) new diagnoses among PWID in 2014, the highest number reported in this 
risk group since 2009. Of the new diagnoses, 85% were Irish-born, 89% were resident in 
Dublin and 89% were co-infected with hepatitis C. Forty one percent of PWID newly diagnosed 
in 2014 were recently infected, with documented previous negative HIV tests in either 2013 or 
2014; also the proportion diagnosed late in 2014 (44%) was lower than in previous years (53% 
in 2013 and 56% in 2012). This increase in recently acquired infections since June 2014 among 
PWID is currently under investigation by the Director of Public Health in Dublin and a detailed 
review of the mode of transmission for cases diagnosed since 2014 is also being carried 
out.  Ascertainment of injecting drug use as a mode of transmission may be improving and 
could account for some of the increase, but the data points to transmission of HIV in this 
population and is of concern. 
 
Information on co-infection with TB was collected for the first time in 2014. Overall 16 people 
(4%) were reported to be co-infected with TB at the time of their HIV diagnosis; 11% of 
heterosexual cases were co-infected with TB.   
 
Forty nine percent of new diagnoses in 2014 were late presenters (with CD4 less than 
350cells/µl or an AIDS defining illness at diagnosis). This is very similar to the proportion in 
recent years (50% in 2013 and 49% in 2012). Late presentation was less common among MSM 
(38%) and PWID (44%) than among heterosexuals (56% in females and 71% in males). Regular 
testing among MSM and PWID is likely to be a major reason for this as both groups had a 
much higher proportion reporting ever having had a previous negative test (58% in MSM and 
                                                                
[1]
 A generalised HIV epidemic is where greater than 1% of the general population is HIV positive 
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66% in PWID versus 20% in heterosexuals). However, the lower proportion of late diagnoses 
among MSM and PWID may also be a result of more recently acquired infections in these 
population groups. Based on previous HIV testing history, 27% of infections in MSM, and 41% 
in PWID were acquired in the previous 2 years. These figures are likely to be an 
underestimate, as not all are being tested on a regular basis, and duration of infection 
information can’t be determined using currently available routine tests.   
 
In light of the continued increase in new HIV diagnoses among MSM, effective interventions 
such as promoting condom use, and peer led outreach interventions that provide information 
and support to the MSM community, need to be sustained and strengthened.  
 
In addition, more emphasis on the benefits of early testing, and ready access to HIV testing 
are needed to reduce the proportions presenting late, which will not only benefit the 
individual detected early, but will also reduce the likelihood of transmission to others.   Recent 
initiatives offering HIV screening to attendees of some emergency departments at large 
hospitals in Dublin may result in earlier detection of infections in people that may otherwise 
be unaware of their infection.   
 
 
Table 1: New HIV diagnoses 2014, summary table 
Number of HIV diagnoses 377 
Rate of diagnoses (per 100,000 population) 8.2 
Age Median age of adult cases 33 years 
 Age range of adult cases 18 to 77 years 
 Young people (15-24 years) 44 (11.7%) 
 Aged 50 and older  32 (8.5%) 
Gender Males 277 (73%) 
 Females  100 (27%) 
 Male to female ratio 2.8 
Route of Transmission Men who have sex with men (MSM) 183 (49%) 
 Heterosexual 125 (33%) 
 PWID (People who inject drugs) 27 (7%) 
 Mother to Child transmission (MTCT) 2 (0.5%) 
 Unknown 40 (11%) 
Geographic origin Born in Ireland 137 (36.3%) 
 Born Abroad 203 (53.8%) 
 Unknown 37 (9.8%) 
Stage of Infection Late  159 (48.6%) 
 Advanced HIV infection 90 (27.5%) 
 Concurrent AIDS diagnosis 38 (10.1%) 
Co-infections Acute STI 39 (10.3%) 
 TB 16 (4.2%) 
 Hepatitis B 18 (4.8%) 
 Hepatitis C 31 (8.2%) 
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1. HIV NEW DIAGNOSES - 2014 
This report presents data on new HIV diagnoses notified in Ireland during 2014. HIV was made 
a notifiable disease in Ireland in September 2011 and since January 2012, cases of HIV have 
been notified via the national Computerised Infectious Disease Reporting (CIDR) system. 
Further information on the enhanced HIV surveillance system can be found at 
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceDocuments/File,13903,en.pdf.  
 
There were 377 new HIV diagnoses notified in Ireland in 2014, giving a crude notification rate 
of 8.2 per 100,000 population. This compares with 341 new notifications in 2013 and 
represents an 11% increase. Between 2010 and 2013, the annual rate of new diagnoses in 
Ireland was stable ranging from 7.0 to 7.5 per 100,000 (see figure 1). A rate of 5.7 per 
100,000, ranging from 2.0 in Croatia to 24.6 in Estonia, was reported in EU/EEA countries in 
2013 (1). 
 
Completed surveillance report forms were received for 336 (89%) of new diagnoses (as of May 
20th 2015). Please note that information from previous years is updated on an ongoing basis 
in CIDR, and so information from previous years represents our current understanding and 
most up to date data, and may not correspond exactly with what was reported in previous 
annual reports.  Similarly, data for 2014 may be updated further in due course and will be 
reported on in subsequent annual reports 
 
Since the early 1980’s and to the end of 2014, 7,353 people have been newly diagnosed with 
HIV in Ireland.  However, this number does not represent the number of people living with 
HIV (PLHIV) in Ireland, as it does not take factors such as death and migration into account.  
 
 
 
Figure 1: Rate of new HIV diagnoses (per 100,000 population), 1991 to 2014 
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1.1 GENDER AND AGE 
In 2014, 277 (73%) new HIV diagnoses were in men (12.2/100,000 population) and 100 (27%) 
were in women (4.3/100,000 population), with a male to female ratio of 2.8. Figure 2 
describes the trends in newly diagnosed HIV infection in males and females from 2003 to 
2014. In 77 of the 100 females (where pregnancy status was available), 10 women (13%) were 
pregnant at HIV diagnosis.  
 
The median age of adult cases at HIV diagnosis was 33 years (range: 18 to 77 years); 33 years 
in males (range: 19-77 years) and 33 years (range: 18 to 65 years) in females. Figure 3 shows 
the rate of new diagnoses in 2014 among males and females. The highest rate of new 
diagnoses in both males and females occurred in those aged 25-29 years at 38 per 100,000 
population and 13 per 100,000 population, respectively.  
 
The highest proportion (45%) of new HIV diagnoses was reported in 25-34 year olds, with 12% 
among young adults (15-24 years) and 9% in those aged 50 and older (see table A1 in 
Appendix 1).  
 
 
Figure 2: New HIV diagnoses by gender, 2003 to 2014 
 
 
Figure 3: Rate of new HIV diagnoses (per 100,000 population) among male and females, 2014 
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1.2 PROBABLE ROUTE OF TRANSMISSION 
Information on probable route of transmission was available for 337 (89%) new diagnoses in 
2014. MSM accounted for the highest number of new diagnoses (183, 49%) as has been the 
case since 2009 (table 2 and figure 4). Heterosexual contact accounted for 125 new diagnoses 
(33%), which is similar to recent years. There were 27 new diagnoses among PWID (7%) which 
is an increase on recent years. There were two cases reported where the route of 
transmission was identified as Mother to Child transmission (MTCT).  
 
For the purpose of this report, the category “MTCT” is included in the category “Unk/Other” 
for most of the tables and figures.  Further information on new diagnoses among MSM, 
heterosexuals and PWID is available later in the report (pages 17-22).  
 
Table 2: New HIV diagnoses by probable route of transmission, 2003 to 2014 
Probable  
route 
transmission 
MSM PWID Hetero MCT Unknown Total 
 No.  % No.  % No.  % No.  % No.  %  
2003 76 19.0 50 12.5 222 55.4 11 2.7 42 10.5 401 
2004 63 17.6 74 20.7 179 50.0 3 0.8 39 10.9 358 
2005 60 18.4 67 20.6 171 52.5 3 0.9 25 7.7 326 
2006 89 25.2 59 16.7 181 51.3 2 0.6 22 6.2 353 
2007 91 23.3 55 14.1 165 42.2 6 1.5 74 18.9 391 
2008 105 26.0 40 9.9 190 47.0 7 1.7 62 15.3 404 
2009 138 34.9 30 7.6 162 41.0 5 1.3 60 15.2 395 
2010 134 40.6 23 7.0 127 38.5 9 2.7 37 11.2 330 
2011 145 44.5 17 5.2 125 38.3 3 0.9 36 11.0 326 
2012 166 48.8 16 4.7 132 38.8 5 1.5 21 6.2 340 
2013 158 46.3 21 6.2 131 38.4 3 0.9 28 8.2 341 
2014 183 48.5 27 7.2 125 33.2 2 0.5 40 10.6 377 
 
 
Figure 4: New HIV diagnoses by probable route of transmission, 2003 to 2014 
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1.3 GEOGRAPHIC ORIGIN (BASED ON COUNTRY OF BIRTH) 
Of the 377 new diagnoses in 2014, 137 (36%) were born in Ireland and 203 (54%) were 
migrants. Information on country of birth was unavailable for the remaining 37 cases (10%).  
 
Of the 203 migrants, the largest number were born in sub-Saharan Africa (82) followed by 
Latin America (43), western Europe (23), central Europe (23), eastern Europe (13) and south 
and southeast Asia (12) (see figure 5).  
 
Geographic origin varied by route of transmission and figure 6 shows the proportions by 
geographic origin for each route of transmission. Just under half of MSM (48%) were born in 
Ireland with 21% from Latin America. Fifty eight percent of heterosexual cases were born in 
sub-Saharan Africa and 15% were Irish born. Eighty five percent of PWID were born in Ireland.  
 
Further information on geographic origin, ethnicity and probable country of infection is 
available in Appendix 1.   
 
 
Figure 5: New HIV diagnoses by geographic origin, 2014 
 
 
Figure 6: New HIV diagnoses by geographic origin and probable route of transmission, 2014 
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1.4 LATE DIAGNOSIS AND ADVANCED HIV INFECTION 
 
 
 
 
 
 
 
 
Late HIV diagnosis, where a person is unaware of their HIV status for many years, carries an 
increased risk of HIV-related illness and death (2). In addition, prompt HIV diagnosis and 
appropriate treatment can provide an opportunity to prevent further HIV transmission. CD4 
count at diagnosis was available for 325 of 377 cases (86%) in 2014. This is slightly less than 
the proportion with CD4 count available in 2013 (89%).  
 
During 2014, 49% of cases were late presenters (where information on CD4 count or AIDS 
defining illness at diagnosis was supplied). This is similar to the proportion in recent years 
(50% in 2013 and 49% in 2012). In 2014, 28% had advanced HIV infection at diagnosis 
compared with 26% in 2013 and 2012. The proportion of late presenters in EU and EEA 
countries in 2013 was 47% (1). 
 
Table 3 presents the 2014 data by CD4 count, gender, probable route of transmission, age 
group and region of origin.  
 
 By risk group, the proportion diagnosed late was highest among heterosexual males 
(71%) followed by heterosexual females (56%), PWID (44%) and was lowest among 
MSM (38%).   
 
 When looking at CD4 count by age group, there is a clear age gradient with increased 
proportions of late diagnosis among older age categories. Four fifths (82%) of those 
aged 50 years and older were diagnosed late compared to 31% among those aged 20-
24 years.   
 
 By region of origin, the proportion diagnosed late was highest among those born in 
sub-Saharan Africa (65%) and was lowest among those born in western Europe (30%).  
 
Figure 8 presents the proportion diagnosed late by probable route of transmission between 
2012 and 2014 and figure 9 presents the proportion diagnosed with advanced HIV infection by 
probable route of transmission between 2012 and 2014. 
 
 
 
 
 
 
 
 
 
Definition: 
Late diagnosis:                          CD4 count of less than <350 cells/µl at diagnosis or an  
AIDS defining illness at diagnosis 
 
Advanced HIV Infection:         CD4 count of <200 cells/µl at diagnosis or an AIDS  
defining illness at diagnosis.  
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Table 3: Frequency of late diagnosis and advanced HIV infection by gender, probable route of 
transmission, age group and region of origin, 2014 
  Proportion 
diagnosed with 
advanced HIV 
infection1 
Proportion 
diagnosed late2  
Total  27.5 48.6 
Gender Female 32.1 54.3 
 Male 26.0 46.7 
Prob Route of Transmission MSM 18.7 38.0 
 PWID 26.1 43.5 
 Hetero- male 46.2 71.1 
 Hetero - female 29.7 56.3 
Age Group (yrs) 20-24 5.7 31.4 
 25-29 19.3 37.3 
 30-34 31.0 49.3 
 35-39 22.0 50.0 
 40-44 35.5 58.1 
 45-49 50.0 62.5 
 50+ 60.0 82.1 
Region of origin Ireland 26.4 46.4 
 Western Europe 25.0 30.0 
 Central & Eastern Europe 17.1 31.4 
 Latin America 19.0 42.9 
 Sub-Saharan Africa 33.3 65.3 
 
 
Figure 8: Proportion with late HIV diagnosis by probable route of transmission, 2012 to 2014 
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Figure 9: Proportion with advanced HIV infection by probable route of transmission, 2012 to 
2014 
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1.5 CLINICAL STAGE OF INFECTION 
At the time of HIV diagnosis in 2014, 204 people (54%) were asymptomatic, 50 (13%) were 
symptomatic (non-AIDS), 38 (10%) had an AIDS defining illness and 9 (2%) had an acute sero-
conversion illness. Information on clinical stage of infection was unavailable for 74 cases 
(20%).  
 
Figure 10 shows the 2014 cases by probable route of transmission and clinical stage of 
infection. 
 
 
 
 
Figure 10: New HIV diagnoses by clinical stage and probable route of transmission, 2014 
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1.6 CO-INFECTIONS 
Table 4 presents data on co-infections with acute infectious syphilis, chlamydia, gonorrhoea, 
TB, hepatitis B and C by probable route of transmission.3  
 
Co-infection with STIs 
People co-infected with HIV and sexually transmitted infections (STIs) are more likely to 
transmit HIV during sex (3). Of the 377 new HIV diagnoses in 2014, 10% were co-infected with 
an acute STI (chlamydia, gonorrhoea and/or syphilis).  
 
By risk group, 19% of MSM and 3% of heterosexuals were co-infected with an acute STI. 
Among MSM, 9% were co-infected with gonorrhoea, 8% with chlamydia and 7% with acute 
infectious syphilis.  
 
Co-infection with TB 
Information on co-infection with TB was collected for the first time in 2014. Sixteen people 
(4%) were co-infected with TB at the time of HIV diagnosis. Among heterosexuals, 11% were 
co-infected with TB.   
 
Co-infection with Hepatitis  
Five percent (18 cases) were co-infected with hepatitis B (including one acute case) and 8% 
(31 cases) were co-infected with hepatitis C (including one acute case).  
 
Among PWID, 89% were co-infected with hepatitis C at the time of their HIV diagnosis.  
 
Table 4: Co-infections with HIV by probable route of transmission, 2014 
 MSM Hetero PWID Total 
Co-infection with  No.  %  No.  % No. % No.  % 
Acute STI  34 18.6 4 3.2 0 0 39 10.3 
Chlamydia 15 8.2 3 2.4 0 0 18 4.8 
Gonorrhoea 17 9.3 1 0.8 0 0 18 4.8 
Acute Infectious Syphilis 13 7.1 0 0.0 0 0 144 3.7 
TB 2 1.1 14 11.2 0 0 16 4.2 
Hepatitis B 7 3.8 10 8.0 0 0 18 4.8 
Hepatitis C 2 1.1 8 6.4 24 88.9 31 8.2 
 
 
 
 
 
 
                                                                
3
 Data on co-infections are obtained from data provided on the HIV enhanced surveillance form. 
4
 The total includes one person where the risk group was unknown 
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1.7 AREA OF RESIDENCE 
The rate of new HIV diagnoses by HSE area of residence5 is shown in table 5. In 2014, the rate 
was highest in HSE-East (16.1 per 100,000) and lowest in the HSE-Southeast (2.0 per 100,000).  
 
Eighty nine percent of PWID newly diagnosed in 2014 were resident in Dublin compared to 
73% of MSM and 62% of heterosexuals.  
 
Table 5: Number of new HIV diagnoses and rate by HSE area of residence, 2014 
HSE Area Counties Number Rate per 100,000 
East Dublin 
Kildare 
 Wicklow 
261 16.1 
Midlands Laois 
Longford 
Offaly 
Westmeath  
15 5.3 
Midwest Limerick 
Clare 
Tipperary North 
18 4.7 
Northeast Louth 
Meath 
Cavan 
Monaghan  
22 5.0 
Northwest Sligo 
Leitrim 
Donegal  
7 2.7 
Southeast Wexford 
Waterford 
Carlow  
Kilkenny 
Tipperary South 
10 2.0 
South Cork 
Kerry 
32 4.8 
West Galway 
Mayo 
Roscommon 
12 2.7 
Total  377 8.2 
 
 
 
 
 
                                                                
5
 If information on area of residence is not available, cases are assigned to the HSE area of the clinician or the 
laboratory. 
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1.8 PREVIOUSLY TESTED POSITIVE ABROAD 
Notifications of HIV include all people who test HIV positive for the first time in Ireland and 
include a number of people who have previously tested HIV positive abroad. Among the 377 
new diagnoses in 2014, 64 (17%) were reported to have previously tested HIV positive abroad. 
This compares to 16% in 2013, 17% in 2012 and 14% in 2011 (data on previous positive test 
was not collected prior to 2011).  
 
Of the 64 cases in 2014 that were previously tested positive abroad, 30 were MSM, 28 were 
heterosexual, four were PWID and two were infected through MTCT. Table 6 describes the 
year of diagnosis of cases with a previous positive test in another country.  
 
 
Table 6: New diagnoses in Ireland in 2014, with previous HIV positive test abroad 
Cases with a previous positive test  64 
In 2013 or 2014 21 
In 2008-2012 24 
Pre 2008 15 
Year unknown 4 
 
 
 1.9 HISTORY OF HIV TESTING  
Of the new diagnoses in 2014, 154 (41%) were reported to have previously tested negative for 
HIV, 91 (24.1%) reported that they did not have a previous negative test and information was 
unavailable for 132 (35%).  
 
Table 7 describes HIV testing history by probable route of transmission. The proportion with a 
history of a previous negative HIV test was highest among PWID (66%) followed by MSM 
(58%) and heterosexuals (20%). The proportion who were infected in either 2013 or 2014 (had 
a previous negative test in either 2013 or 2014) was highest among PWID (41%), followed by 
MSM (27%) and lowest among heterosexuals (5%). 
 
 
Table 7: New diagnoses in Ireland by probable route of transmission and HIV testing history, 2014  
 MSM Hetero PWID Unk/Other Total 
 No % No % No % No % No % 
Previous negative 
test In 2013/2014 
49 26.8 6 4.8 11 40.7 0 0.0 66 17.5 
Previous negative 
test pre 
2013/year 
unknown 
57 31.1 19 15.2 7 25.9 5 11.9 88 23.3 
No previous 
negative test 
38 20.8 46 36.8 4 14.8 3 7.1 91 24.1 
Unknown 39 21.3 54 43.2 5 18.5 34 81.0 132 35.0 
Total 183 100.0 125 100.0 27 100.0 42 100.0 377 100.0 
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2. MEN WHO HAVE SEX WITH MEN (MSM) 
 
MSM remain the population most affected by HIV in Ireland. In 2014, there were 183 new HIV 
diagnoses reported among MSM; this compares to 158 in 2013 (+16%) and is the highest 
number of new HIV diagnoses in MSM ever reported in Ireland. New HIV diagnoses among 
MSM accounted for 49% of all diagnoses reported in 2014. In the 10 years since 2005, the 
number of new diagnoses among MSM has increased threefold (from 60 to 183). Male to 
male transmission is also the predominant mode of transmission in western Europe, and 
accounted for 43% of new diagnoses in 2013 (1). 
 
Age  
The median age of MSM at HIV diagnosis in 2014 was 31 years (range 19-71 years). The 
median age among those newly diagnosed has decreased in recent years (from 37 years in 
2005). The largest proportion (28%) of new diagnoses among MSM occurred in 25-29 year 
olds. Figure 11 shows increasing numbers in this age group with a fivefold increase since 2005. 
Fourteen percent (26 cases) of new diagnoses among MSM were aged 15-24 years and 8% 
were over 50 years old.  
 
Region of origin 
Just under half (48%) of new diagnoses among MSM were born in Ireland, 21% in Latin 
America, 9% in western Europe and 9% in central and eastern Europe. The number of cases 
among foreign-born MSM has increased in recent years, largely due to an increase in the 
number of cases born in Latin America (see figure 12).  
 
Stage of infection  
Thirty eight percent of MSM were diagnosed late in 2014. This is the same as the proportion 
diagnosed late in 2013 and very similar to the proportion late in 2012 (39%). Nineteen percent 
of MSM were diagnosed with advanced HIV infection.  
 
Sixteen MSM (9%) were diagnosed with an AIDS defining illness at the time of their HIV 
diagnosis.  The most common indicative illness in 2014 among MSM was PCP (63%).  
 
Over a quarter (27%) of MSM newly diagnosed with HIV were infected in either 2013 or 2014 
 
Co-infections with an acute STI 
Nineteen percent of MSM (34) were co-infected with an acute STI (chlamydia, gonorrhoea or 
syphilis) at the time of their HIV diagnosis.  
 
Previously positive 
Of the new diagnoses among MSM, 16% (30) had previously tested HIV positive abroad. 
 
  
Health Protection Surveillance Centre (HPSC), 25-27 Middle Gardiner St, Dublin 1  18 
 
 
Figure 11: New HIV diagnoses among MSM by age group, 2005 to 2014 
 
 
 
Figure 12: New HIV diagnoses among MSM by region of birth, 2003 to 2014 
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3. HETEROSEXUALS 
 
People who acquired their infection through heterosexual contact accounted for 125 (33%) of 
new HIV diagnoses in Ireland in 2014, a decrease of 5% compared to 131 cases in 2013. Since 
2010, the number of new diagnoses among heterosexuals has remained fairly stable between 
125 and 133 cases.  
 
Age and gender  
Seventy one (57%) new diagnoses among heterosexuals were female and 54 (43%) were male. 
The median age at diagnosis in 2014 was 35 years (range 18 to 71), 39 years in males (range 
24 to 70 years) and 34 years in females (range 23 to 71 years). Among heterosexual males, 
18% were aged 50 and older compared to 4% among heterosexual females.  Seven percent of 
heterosexual cases were in young people (15-24 years).  
 
Subcategory of heterosexual risk 
Table 8 describes new HIV diagnoses in persons infected through heterosexual transmission 
by transmission subcategory. The majority of heterosexual cases (62%) were born in a country 
with a generalised HIV epidemic6. Figure 13 shows the number of heterosexual cases 
originating in a country with a generalized epidemic and all other heterosexual cases from 
2003 to 2014.  
 
Region of origin 
Of the heterosexual cases, 73 (58%) were born in sub-Saharan Africa (26 male and 47 female), 
19 (15%) in Ireland (11 male and 8 female), 15 (12%) in central and eastern Europe (4 male 
and 11 female) and 6 (5%) in western Europe (4 male and 2 female).  
 
Stage of infection  
Sixty three percent of heterosexual cases were diagnosed late in 2014 (71% in males and 56% 
in females). The proportion diagnosed late in male heterosexuals in 2014 was higher than in 
2013 (60%) and 2012 (68%). The proportion diagnosed late in females was similar to the 
proportion late in 2013 (59%) and 2012 (58%). Thirty seven percent had advanced HIV 
infection at diagnosis (46% in males and 30% in females).  
 
Eighteen people (14%) were diagnosed with an AIDS defining illness at the time of their HIV 
diagnosis (11 male and 7 female). 
 
Previously positive 
28 heterosexuals (22%) were previously diagnosed HIV positive in another country.  
 
Co-infection with TB  
Information on co-infection with TB was collected for the first time in 2014. Among 
heterosexuals, 11% were co-infected with TB.   
 
 
                                                                
6
 A generalised HIV epidemic is where greater than 1% of the general population is HIV positive 
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Table 8: New HIV diagnoses in persons infected through heterosexual transmission by 
transmission subcategory, 2014 
Subcategory of heterosexual transmission No. % 
Originating from a country with generalised HIV epidemic 77 61.6 
Sex with a person from a country with generalised HIV epidemic 8 6.4 
Sex with a person known to be HIV+, none of the above 5 4.0 
Sex with a high risk partner 2 1.6 
Presumed to be infected heterosexually, no further data on risk factors and HIV 
status of partners 
33 26.4 
Total 125 100.0 
 
 
 
Figure 13: Trends in new diagnoses by heterosexual subcategory, 2003 to 2014 
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4. PEOPLE WHO INJECT DRUGS (PWID) 
In 2014, 27 new HIV diagnoses (7%) were among PWID. This is an increase of 29% compared 
to the number diagnosed in 2013 (21).  
 
Age and Gender 
Of the 27 new diagnoses among PWID, 14 (52%) were female and 13 (48%) were male, giving 
a male to female ratio of 0.9.  Figure 14 describes the changing trend in male and female cases 
between 2003 and 2014. The number of new diagnoses in females has increased from 3 in 
2012 to 14 in 2014. The median age at diagnosis among PWID was 32 years (range: 24 to 49 
years) both in males and females.   
 
Region of Origin  
Of the 27 new diagnoses, 85% (23) were born in Ireland and 2 (9%) were born in central and 
eastern Europe. Country of birth was unknown for the remaining two cases.  
 
HSE area of residence 
89% (24) of PWID were resident in HSE East at diagnosis.  
 
Stage of infection 
Forty four percent of PWID were diagnosed late in 2014 including 26% who were severely 
immuno-compromised. The proportion diagnosed late in 2014 is lower than in previous years 
(53% in 2013 and 56% in 2012).   
 
Forty one percent of PWID newly diagnosed with HIV in 2014 were infected in either 2013 or 
2014.   
 
Co-infection with Hepatitis C 
89% (24) of PWID newly diagnosed with HIV in 2014 were co-infected with Hepatitis C. 
 
Duration of drug use 
Where information was available (for 11 cases), the median duration of injecting drug use 
among PWID newly diagnosed with HIV in 2014 was 8 years. 
 
Figure 14: New HIV diagnoses among PWID by gender, 2003 to 2014  
0
5
10
15
20
25
30
35
40
45
50
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
N
u
m
b
e
r 
o
f 
ca
se
s
Year of diagnosis
Male Female
  
Health Protection Surveillance Centre (HPSC), 25-27 Middle Gardiner St, Dublin 1  22 
 
5. MOTHER TO CHILD TRANSMISSION  
There were two cases notified to CIDR in 2014 where the route of transmission was identified 
as mother to child transmission (MTCT). The country of infection was sub-Saharan Africa for 
both children. 
 
The Rainbow Clinic in Our Lady’s Children’s Hospital in Crumlin reported that there were 70 
babies born to HIV infected mothers in Ireland during 2014. At the time of this report, (based 
on serial HIV PCR testing); 61 of these infants are not infected and 9 remain of indeterminate 
status (i.e. do not meet the criteria for HIV infection and are <18 months at time of test). 
There was no mother to child transmissions in Ireland in 2014 (Personal communication; 
Michelle Goode, May 2015). 
 
 
 
 
6. DEATHS DUE TO HIV AND AIDS IN 2014 
Of the 377 HIV notifications made to CIDR in 2014, one person was reported to have died.   
 
The data presented in table 9 are deaths reported to the CSO in 2014 where cause of death is 
AIDS or HIV and they are taken from the CSO Vital Statistics 2014 Annual Report (available at 
http://www.cso.ie/en/releasesandpublications/birthsdeathsandmarriages/)  
 
There were 9 deaths reported to the CSO in 2014 where the cause of death was AIDS or HIV, 6 
in males and 3 in females.  
 
 Table 9: Number of deaths reported in 2014 where cause of death is AIDS or HIV (Source: 
Vital Statistics Reports, CSO).  
  Age Group (years) 
 15-24 25-34 35-44 45-54 55+ Total 
Male 0 1 1 2 2 6 
Female 0 1 2 0 0 3 
Total 0 2 3 2 2 9 
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TECHNICAL NOTES 
 Data for this report were extracted from CIDR on May 20th 2015 and were correct at the time 
of publication.  
 Percentages are rounded up in the text and are provided to one decimal place in the tables. 
 For the purposes of this report, “Mother to Child Transmission” cases were included in the 
category “Unk/Other” for many of the tables and figures.   
 
OTHER SOURCES OF DATA  
 Weekly, quarterly and annual reports on the epidemiology of HIV in Ireland can be found at  
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceReports/  
 Reports on HIV antenatal screening can be found at 
http://www.hpsc.ie/A-
Z/HIVSTIs/HIVandAIDS/AntenatalHIVTesting/ReportsonAntenatalHIVTestinginIreland/   
 The case definition for HIV can be found on the HPSC website at 
http://www.hpsc.ie/NotifiableDiseases/CaseDefinitions/  
 The enhanced surveillance form for HIV can be found at  
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceDocuments/Surveillanceforms/  
 Data on laboratory testing of HIV can be found at  
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceDocuments/  
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APPENDIX 1: 2014 TABLES 
 
Table A1:  HIV diagnoses by age group and route of transmission, 2014 
Age Group MSM Hetero - 
Male 
Hetero - 
Female 
PWID Unk/Other Total 
Age Group N % N % N % N % N % N % 
<15 0 0.0 0 0.0 0 0.0 0 0.0 3 7.1 3 0.8 
15-19  2 1.1 0 0.0 1 1.4 0 0.0 0 0.0 3 0.8 
20-24  24 13.1 1 1.9 7 9.9 3 11.1 6 14.3 41 10.9 
25-29  52 28.4 7 13.0 17 23.9 7 25.9 6 14.3 89 23.6 
30-34  35 19.1 11 20.4 18 25.4 8 29.6 9 21.4 81 21.5 
35-39  26 14.2 8 14.8 13 18.3 7 25.9 6 14.3 60 15.9 
40-44 17 9.3 10 18.5 7 9.9 1 3.7 5 11.9 40 10.6 
45-49 13 7.1 7 13.0 5 7.0 1 3.7 2 4.8 28 7.4 
>50  14 7.7 10 18.5 3 4.2 0 0.0 5 11.9 32 8.5 
Total 183 100.0 54 100.0 71 100.0 27 100.0 42 100.0 377 100.0 
 
Table A2:  HIV diagnoses by age group and gender, 2014 
Age Group (yrs) Male Female Total 
 N % N % N % 
<15 0 0.0 3 3.0 3 0.8 
15-19 2 0.7 1 1.0 3 0.8 
20-24  30 10.8 11 11.0 41 10.9 
25-29  65 23.5 24 24.0 89 23.6 
30-34 56 20.2 25 25.0 81 21.5 
35-39  43 15.5 17 17.0 60 15.9 
40-44 31 11.2 9 9.0 40 10.6 
45-49  22 7.9 6 6.0 28 7.4 
50+ 28 10.1 4 4.0 32 8.5 
Total 277 100.0 100 100.0 377 100.0 
 
Table A3:  HIV diagnoses by route of transmission and geographic origin, 2014  
 MSM Hetero - 
male 
Hetero - 
female 
PWID Unk/Other Total 
Geographic Origin N % N % N % N % N % N % 
Ireland 87 47.5 11 20.4 8 11.3 23 85.2 8 19.0 137 36.3 
W Europe 17 9.3 4 7.4 2 2.8 0 0.0 0 0.0 23 6.1 
C&E Europe 17 9.3 4 7.4 11 15.5 2 7.4 2 4.8 36 9.5 
SS Africa 3 1.6 26 48.1 47 66.2 0 0.0 6 14.3 82 21.8 
Latin America 39 21.3 2 3.7 1 1.4 0 0.0 1 2.4 43 11.4 
S&SE Asia 7 3.8 4 7.4 1 1.4 0 0.0 0 0.0 12 3.2 
Other 5 2.7 2 3.7 0 0.0 0 0.0 0 0.0 7 1.9 
Unknown 8 4.4 1 1.9 1 1.4 2 7.4 25 59.5 37 9.8 
Total 183 100.0 54 100.0 71 100.0 27 100.0 42 100.0 377 100.0 
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Table A4:  HIV diagnoses by gender and geographic origin, 2014 
Region Of Origin Male Female Total 
 No. % No. % No. % 
Ireland 116 41.9 21 21.0 137 36.3 
Sub Saharan Africa 31 11.2 51 51.0 82 21.8 
Latin America 42 15.2 1 1.0 43 11.4 
Central Europe 19 6.9 4 4.0 23 6.1 
Western Europe 21 7.6 2 2.0 23 6.1 
Eastern Europe 5 1.8 8 8.0 13 3.4 
South and South East Asia 11 4.0 1 1.0 12 3.2 
Other 7 2.5 0 0.0 7 1.9 
Unknown 25 9.0 12 12.0 37 9.8 
Total 277 100.0 100 100.0 377 100.0 
 
Table A5:  HIV diagnoses by route of transmission and ethnicity, 2014 
Ethnicity MSM Hetero PWID Unk/Other Total 
 N % N % N % N % N % 
White 127 69.4 37 29.6 25 92.6 7 16.7 196 52.0 
Black African 3 1.6 68 54.4 0 0.0 5 11.9 76 20.2 
Mixed background 14 7.7 1 0.8 0 0.0 0 0.0 15 4.0 
Other 8 4.4 3 2.4 0 0.0 0 0.0 11 2.9 
Not known 31 16.9 16 12.8 2 7.4 30 71.4 79 21.0 
Total 183 100.0 125 100.0 27 100.0 42 100.0 377 100.0 
 
Table A6:  HIV diagnoses by route of transmission and probable region of infection, 2014 
Probable region of 
infection 
MSM Hetero PWID Unk/Other Total 
No.  % No.  % No.  % No.  % No.  % 
Ireland 101 55.2 26 20.8 20 74.1 5 11.9 152 40.3 
Sub Saharan Africa 1 0.5 55 44.0 0 0.0 5 11.9 61 16.2 
Western Europe 12 6.6 6 4.8 2 7.4 0 0.0 20 5.3 
Central & Eastern Europe 3 1.6 6 4.8 2 7.4 0 0.0 11 2.9 
Latin America 22 12.0 4 3.2 0 0.0 0 0.0 26 6.9 
Other 9 4.9 3 2.4 0 0.0 1 2.4 13 3.4 
Unknown 35 19.1 25 20.0 3 11.1 31 73.8 94 24.9 
Total 183 100.0 125 100.0 27 100.0 42 100.0 377 100.0 
Table A7: Reason for HIV test by gender and route of transmission, 2014 
 Gender Probable route of transmission  
Total Reason for Test Female Male MSM Hetero PWID Unk/Oth 
Antenatal 8 0 0 7 0 1 8 
Asylum seeker screening 15 11 2 24 0 0 26 
Known positive partner 5 20 15 10 0 0 25 
STI screen 17 60 52 18 6 1 77 
Risky behaviour 3 58 49 6 6 1 61 
Symptomatic 27 68 37 39 10 9 95 
Other 6 15 8 8 3 2 21 
Unknown 19 45 20 13 2 28 64 
Total 100 277 183 125 27 42 377 
 
